Dr. Scholz is a neurologist and geneticist specializing in neurodegenerative disorders such as Parkinson's disease, atypical parkinsonism and dementia syndromes. She received her medical degree from the Medical University Innsbruck, Austria. Following graduation, she was a postdoctoral fellow at the National Institutes of Health under the supervision of Drs. Andrew Singleton and John Hardy. She obtained a Ph.D. in neurogenomics from the University College London, UK in 2010. She then moved to Baltimore to complete her neurology residency training at Johns Hopkins. In 2015 Dr. Scholz received the McFarland Transition to Independence Award for Neurologist-Scientists. She is Lasker Clinical Research Scholar at the National Institute of Neurological Disorders and Stroke focusing on genetic causes of neurodegenerative syndromes, and an adjunct faculty member at Johns Hopkins' department of neurology. Dr. Scholz is rated as an Elite provider by MediFind in the treatment of Lewy Body Dementia (LBD). Her top areas of expertise are Lewy Body Dementia (LBD), Multiple System Atrophy, Movement Disorders, and Parkinson's Disease.

Liana Rosenthal, M.D. is an Assistant Professor in the Department of Neurology at Johns Hopkins University School of Medicine in Baltimore, Maryland. Dr. Rosenthal completed medical school at Johns Hopkins with an internship at Johns Hopkins Bayview Medical Center. She completed her neurology residency and movement disorder fellowship at The Johns Hopkins Hospital. Dr. Rosenthal is rated as an Advanced provider by MediFind in the treatment of Lewy Body Dementia (LBD). Her top areas of expertise are Movement Disorders, Parkinson's Disease, Olivopontocerebellar Atrophy, and Spinocerebellar Ataxia.

Dr. Alexander Pantelyat cares for patients with movement disorders such as Parkinson's disease and related syndromes, essential tremor, dystonia, chorea and normal pressure hydrocephalus. He also provides botulinum toxin injections for movement disorders and is involved in deep brain stimulation programming and intraoperative neurophysiological monitoring.His research explores atypical parkinsonian disorders, such as dementia with Lewy bodies, progressive supranuclear palsy, corticobasal syndrome/degeneration and multiple system atrophy; cognitive aspects of movement disorders; and music-based rehabilitation of neurodegenerative diseases.Dr. Pantelyat earned his medical degree from Temple University School of Medicine in Philadelphia, where he was elected a member of the Alpha Omega Alpha Honor Medical Society and received the Matthew T. Moore Prize in Neurology. He completed his residency training in Neurology ​at the University of Pennsylvania in Philadelphia, and a fellowship in movement disorders at the University of Pennsylvania/Philadelphia VA Medical Center. As part of his fellowship, Dr. Pantelyat also completed the Clinical Research Certificate Program at the Center for Clinical Epidemiology and Biostatistics. He is a 2013 American Academy of Neurology Palatucci Advocacy Leader and grant recipient. Dr. Pantelyat is rated as an Advanced provider by MediFind in the treatment of Lewy Body Dementia (LBD). His top areas of expertise are Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Corticobasal Degeneration.

A native of Athens, Greece, Professor Lyketsos graduated from Northwestern University with a BA in Psychology and from Washington University Medical School in St. Louis with a Medical Doctorate. He completed residency and Chief Residency in psychiatry at Johns Hopkins, as well as a fellowship in clinical epidemiology. An active clinician, teacher, and researcher, Dr. Lyketsos is a world expert in the care and treatment of patients with Alzheimer’s and related dementias (ADRD). He carried out pioneering work on the epidemiology and treatment of neuropsychiatric features of AD. His team is developing biomarkers to accelerate treatment development for AD while designing and implementing innovative clinical trials. He leads efforts to ensure the provision of state-of-the-art Dementia Care for people with dementia in the community. Dr. Lyketsos is the Elizabeth Plank Althouse Professor at Johns Hopkins University. He directs the Johns Hopkins Bayview Department of Psychiatry and Behavioral Sciences, as well as the Richman Family Precision Medicine Center of Excellence in Alzheimer’s Disease and the Memory and Alzheimer’s Treatment Center. He is the recipient of multiple awards including the 2022 Argo Award for Science from the President of the Hellenic Republic. He has authored/co-authored over 450 peer-reviewed articles, chapters, commentaries, as well as five books. His work has been cited over 76,000 times with an h-index of 149. A 2021 Stanford University publication reported that he ranked #13 out of 9,246 scientists worldwide (all-time) in the field of Geriatrics. Castle-Connolly has named Dr. Lyketsos as one of America’s Top Doctors every year since 2001. A listing of Dr. Lyketsos’ publications can be found at: https://www.ncbi.nlm.nih.gov/myncbi/constantine.lyketsos.1/bibliography/public/. Dr. Lyketsos is rated as an Advanced provider by MediFind in the treatment of Lewy Body Dementia (LBD). His top areas of expertise are Dementia, Alzheimer's Disease, Lewy Body Dementia (LBD), Cerebellar Degeneration, and Deep Brain Stimulation.

Dr. Esther Oh is a Professor of Medicine, Psychiatry and Behavioral Sciences and Pathology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise is in evaluation and management of memory disorders. She has an extensive experience in evaluating memory disorders in older adults with multiple chronic diseases, and takes and integrative approach in the treatment of memory disorders. Dr. Oh also serves as the co-director of the Johns Hopkins Memory and Alzheimer’s Treatment Center. Dr. Oh earned her M.D. from the UHS/Chicago Medical School. She completed her residency in internal medicine at the University of Illinois at Chicago where she was a chief resident. She completed a fellowship in geriatric medicine and gerontology at Johns Hopkins University School of Medicine, and received her Ph.D. from the Johns Hopkins Bloomberg School of Public Health. Dr. Oh has received numerous awards including the Merck New Investigator Award, AFAR New Investigator Award in Alzheimer’s disease, and the Johns Hopkins Clinical Research Scholars Award. She is also a recipient of several major grants from the National Institute on Aging (NIA). She has also been honored for her teaching by Excellence in Teaching Award in the Division of Geriatric Medicine and Gerontology in 2013 and 2017. Dr. Oh’s research is primarily focused on Alzheimer’s disease and related disorders. Her current projects include: development of biomarkers for detecting early stages of Alzheimer’s disease; understanding the interrelationship between delirium and Alzheimer’s disease; cognitive changes after surgery; and understanding the role of sensory problems (hearing and vestibular function) in Alzheimer’s disease. Dr. Oh is rated as an Advanced provider by MediFind in the treatment of Lewy Body Dementia (LBD). Her top areas of expertise are Delirium, Alzheimer's Disease, Dementia, Deep Brain Stimulation, and Liver Transplant.

Robert Paschall is a Neurologist in Salisbury, Maryland. Dr. Paschall is rated as a Distinguished provider by MediFind in the treatment of Lewy Body Dementia (LBD). His top areas of expertise are Epilepsy, Stroke, Memory Loss, Seizures, and Gastrostomy. Dr. Paschall is currently accepting new patients.

Howard Weiss is a Neurologist in Baltimore, Maryland. Dr. Weiss is rated as a Distinguished provider by MediFind in the treatment of Lewy Body Dementia (LBD). His top areas of expertise are Movement Disorders, Parkinson's Disease, Lewy Body Dementia (LBD), and Secondary Parkinsonism.

Dr. George Ricaurte has a weekly clinic that focuses on Parkinsons disease and other movement disorders. In addition, he attends on the consult and in-patient neurology services at Johns Hopkins Bayview Medical Center. Dr. Ricaurte's research interests center on amphetamine-type stimulants and their potential to damage brain monoamine-containing neurons, including dopamine neurons (which degenerate in Parkinsons disease). Dr. Ricaurte and his colleagues are particularly interested in mechanisms of dopamine nerve cell degeneration. The long-term goal of this neurotoxicology research is to help find ways to prevent - or retard - the progression of Parkinsons disease and related neurodegenerative disorders. Dr. Ricaurtes work also has implications for the drug abuse field and substance abuse neuropsychiatric disorders. Dr. George Ricaurte received his medical degree from Northwestern University Medical School and his doctorate in Pharmacology from the University of Chicago. He then completed his residency in neurology at Stanford University Medical Center and did a one year fellowship at the Parkinsons Institute in California. Dr. Ricaurte is rated as an Advanced provider by MediFind in the treatment of Lewy Body Dementia (LBD). His top areas of expertise are Parkinson's Disease, Movement Disorders, Lewy Body Dementia (LBD), and Essential Tremor.

Michele Bellantoni, M.D., an associate professor of medicine in the Division of Geriatric Medicine and Gerontology at The Johns Hopkins University School of Medicine, is associate director for post-acute and long-term care at Johns Hopkins Bayview Medical Center. She also serves as medical director of the Johns Hopkins Bayview specialty hospital programs. Dr. Bellantoni's clinical interests focus on osteoporosis, geriatrics and using a holistic approach to osteoporosis management in older adults in outpatient settings. She also researches post-menopausal osteoporosis in elderly women and the use of heel ultrasounds as a screening test for osteoporosis. Dr. Bellantoni is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Paget's Disease of Bone, and Lewy Body Dementia (LBD).

Milap Nowrangi, M.D., MS, is an assistant professor of psychiatry and behavioral sciences at The Johns Hopkins University School of Medicine. Dr. Nowrangi specializes in the diagnosis and treatment of age-related cognitive disorders, including Alzheimer's Disease and related dementias. He also is interested in the treatment or management of behavioral and cognitive sequelae of neurological diseases, including those caused by traumatic brain injury, stroke, epilepsy or toxic exposures. Dr. Nowrangi is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). His top areas of expertise are Alzheimer's Disease, Dementia, Bipolar Disorder (BPD), and Neuronal Intranuclear Inclusion Disease (NIID).

1988-1992, Assistant Professor, Department of Pharmacology, Semmelweis Medical University, Budapest, Hungary. 1992-1996, Instructor, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. 2001-2014, Assistant Professor, Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD. 2012-2014, Assistant Professor, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD. 2014-present, Associate Professor, Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD. 2014-present, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD. Dr. Yasar is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). Her top areas of expertise are Normal Pressure Hydrocephalus, Congenital Cardiovascular Shunt, Dementia, and Alzheimer's Disease.

Dr. Ariel Green is Associate Professor of Medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include geriatric medicine and general internal medicine, with a particular interest in reducing use of potentially harmful medications in older adults. Dr. Green earned her medical degree, Master of Public Health and PhD in Clinical Investigation from Johns Hopkins University. She completed her residency in internal medicine at Johns Hopkins Bayview Medical Center and performed a fellowship in geriatric medicine at Johns Hopkins. Her research, supported by the National Institute on Aging, is evaluating the impact on patient and caregiver outcomes of pragmatic interventions to optimize prescribing for older adults with dementia in primary care. Dr. Green is a core faculty member of the Johns Hopkins Bloomberg School of Public Health Center for Drug Safety and Effectiveness. She is also a member of the American Geriatrics Society Clinical Practice and Models of Care Committee. She co-authored The American Geriatrics Society’s recommendations for Choosing Wisely, a national initiative that aims to promote conversations between patients and doctors about avoiding unhelpful medical tests and treatments. A former journalist, Dr. Green has published personal essays and op-eds in Annals of Internal Medicine, The Washington Post, and The New York Times, among other publications. She has been recognized with several awards, including the American Geriatrics Society Choosing Wisely Champion Award. Dr. Green is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). Her top areas of expertise are Dementia, Microscopic Polyangiitis, Lewy Body Dementia (LBD), and Reticuloendotheliosis.

Dr. Ankur Butala specializes in the care of persons with complex neuropsychiatric conditions, including persons with advanced Parkinson Disease or other movement or neurodegenerative disorders. Upon graduating from a selective Physician-Scientist program at Albany Medical College, he joined the University of Massachusetts in an uncommon residency in both Neurology and Psychiatry. Dual-trained neuropsychiatrists such as Dr. Butala have experience with: Parkinson Disease and atypical Parkinsonism, Huntington Disease, Ataxia, Dystonia, early-onset dementia, traumatic brain injury and chronic traumatic encephalopathy, autism spectrum disorders, medication refractory mood and psychotic disorders, epilepsy and functional neurological disorders. In residency, he developed an interest in circuit models of brain function and how non-pharmacological approaches such as Neuromodulation and brain stimulation may be used to address treatment-resistant conditions. Consequently, he joined Johns Hopkins University School of Medicine as a Clinical and Research Fellow from 2015 to 2018, where he developed a skill set including deep brain stimulation, non-invasive brain stimulation (tDCS), and measurement of eye movements. Currently, Dr. Butala's clinical and research interests are in diagnosing and managing persons with advanced Parkinson's Disease, movement disorders, and neuropsychiatric conditions using neuromodulation, cannabinoids, and entheogens. He has ongoing multidisciplinary collaborations with colleagues at the Whiting School of Engineering - Center of Speech & Language Processing in using Machine-Learning Models and Artificial Intelligence to improve the detection and diagnosis of Movement and Neuropsychiatric disorders. LinkedIn https://www.linkedin.com/in/ankurbutalamd Videos Neurology: Junior Faculty Spotlight. Dr. Butala is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). His top areas of expertise are Parkinson's Disease, Corticobasal Degeneration, Movement Disorders, Drug Induced Dyskinesia, and Deep Brain Stimulation.

Dr. Jee Bang cares for patients with disorders of cognition and movement, such as Huntington disease, progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy, dementia with Lewy bodies, frontotemporal dementia, and Alzheimer disease. Dr. Bang is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). Her top areas of expertise are Huntington Disease, Mcleod Neuroacanthocytosis Syndrome, Supranuclear Ocular Palsy, and Progressive Supranuclear Palsy.

Dr. Argye Hillis is a professor of Neurology, with joint faculty appointments in Physical Medicine and Rehabilitation and in Cognitive Science. She is also the Sheikh Khalifa Stroke Institute Professor of Acute Stroke Diagnoses and Management. Prior to medical training and neurology residency, Dr. Hillis worked as a speech-language pathologist, and conducted clinical research focusing on understanding and treating aphasia and hemispatial neglect. She has brought these areas of experience to impact on her clinical research in neurology, which involves cognitive and neuroimaging studies of aphasia and hemispatial neglect due to acute stroke and focal dementias. She has published extensively on these topics in journals and textbooks. Dr. Hillis is Associate Editor of Stroke and has served as Associate editor of Brain, Annals of Neurology, Aphasiology, American Journal of Speech-Language Pathology, Neurocase, Cognitive Neuropsychology, and Language and Cognitive Processes and served as co-Editor and Chief of Behavioral Neurology. Dr. Hillis serves as the Executive Vice Chair of the Department of Neurology and the Director of the Cerebrovascular Division of Neurology at Johns Hopkins. Dr. Hillis is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). Her top areas of expertise are Primary Progressive Aphasia, Stroke, Frontotemporal Dementia, Thrombectomy, and Gastrostomy.

Shakunmala Gupta is a primary care provider, practicing in Hospital Medicine in Columbia, Maryland. Dr. Gupta is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). Her top areas of expertise are Dementia, Movement Disorders, Parkinson's Disease, and Anemia.

Dr. Chua is an assistant professor in the Department of Neurology and Division of Movement Disorders at Johns Hopkins. He received his training at the University of Michigan, where he obtained medical and graduate degrees, then completed a residency in neurology and a combined clinical/research fellowship in movement disorders and neurodegeneration. Dr. Chua’s primary research interests are in neurodegenerative disease with a special focus on autophagy — an essential housekeeping process in cells that is particularly important for the health of neurons. Autophagy may provide a way to break down the buildup of toxic proteins found in neurodegenerative diseases, thereby forming the basis of new treatment strategies for these incurable conditions. He has received multiple research grants to support his work, including from the National Institute of Neurological Disorders and Stroke and the American Academy of Neurology (AAN). He is the primary author and co-author of multiple peer-reviewed scientific publications and online learning modules as part of the AAN. Dr. Chua is a contributing author to The Little Black Book of Neurology by Osama Zaidat, Alan Lerner and J. Douglas Miles, and he has been a peer reviewer for the scientific journals Autophagy, eLife and Neurobiology of Disease. He currently serves on the scientific advisory board for the Don't Forget Morgan Foundation, a private organization supporting research and outreach regarding the disease beta-propeller protein-associated neurodegeneration (BPAN). For more information about the Chua Lab, please visit https://chualab.jhmi.edu. Dr. Chua is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). His top areas of expertise are Primary Lateral Sclerosis, Parkinson's Disease, Movement Disorders, and Camptocormism.

Dennis Dey is a Neurologist in Cumberland, Maryland. Dr. Dey is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). His top areas of expertise are Stroke, Headache, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Transient Ischemic Attack (TIA). Dr. Dey is currently accepting new patients.

Prior to joining the Mid-Atlantic Epilepsy and Sleep Center, Dr. Jonathan Ross was Director of The New England Epilepsy Institute, a division of New England Neurological Associates (NENA) in Lawrence, Massachusetts. He also served as head of the Neurology division at NENA. After graduating medical school in 1991, Dr. Ross completed postgraduate training at Harvard Medical School and Boston University School of Medicine, and also served as Teaching Fellow at Harvard and Boston University. Dr. Ross is an active member of the American Epilepsy Society, American Clinical Neurophysiology Society, Massachusetts Medical Society, and the American Academy of Neurology. Dr. Ross is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). His top areas of expertise are Seizures, Memory Loss, Autosomal Dominant Partial Epilepsy with Auditory Features, and Benign Rolandic Epilepsy.

Cynthia Fields is a Psychiatrist and a Geriatrics provider in Lutherville, Maryland. Dr. Fields is rated as an Experienced provider by MediFind in the treatment of Lewy Body Dementia (LBD). Her top areas of expertise are Major Depression, Seasonal Affective Disorder (SAD), Alzheimer's Disease, and Bipolar Disorder (BPD).